Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
Shenzhen Vital New Material
301319
5
ChengDu Sheng Nuo Biotec
688117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.18%89.45B | 35.25%27.04B | 8.76%22.1B | 6.06%20.04B | -1.24%20.28B | 0.04%79.74B | -11.91%19.99B | -1.31%20.32B | 5.05%18.9B | 11.35%20.53B |
Operating revenue | 11.67%134.13B | 43.42%40.71B | 5.73%33.12B | 4.70%29.95B | -4.56%30.35B | -4.60%120.12B | -20.02%28.38B | -4.46%31.33B | 0.99%28.6B | 8.52%31.81B |
Excise taxes | 8.68%27.42B | 19.20%7.98B | 9.48%6.99B | 5.18%6.21B | -0.11%6.23B | 1.51%25.23B | -6.98%6.7B | 0.57%6.38B | 3.77%5.91B | 11.17%6.24B |
Cost of revenue | 11.00%43.62B | 34.64%12.52B | 7.33%10.97B | 4.40%10.06B | -0.72%10.06B | -2.80%39.29B | -15.33%9.3B | -3.99%10.22B | 2.79%9.64B | 7.62%10.13B |
Gross profit | 13.33%45.84B | 35.78%14.51B | 10.20%11.12B | 7.79%9.98B | -1.76%10.22B | 2.95%40.45B | -8.71%10.69B | 1.56%10.09B | 7.52%9.26B | 15.24%10.4B |
Operating expense | 12.27%24.33B | 36.08%6.78B | 12.56%5.94B | 4.47%6.03B | -3.20%5.39B | -0.97%21.67B | -20.79%4.98B | -12.03%5.28B | 24.72%5.77B | 13.03%5.57B |
Selling and administrative expenses | 12.61%26.39B | 34.15%7.69B | 12.90%6.39B | 5.34%6.41B | -0.93%5.91B | -2.22%23.44B | -15.17%5.73B | -8.93%5.66B | 5.22%6.09B | 14.26%5.96B |
-Selling and marketing expense | 11.17%20.19B | 33.33%5.8B | 10.76%4.86B | 3.97%4.96B | -1.77%4.58B | -3.04%18.16B | -17.94%4.35B | -10.46%4.38B | 6.26%4.77B | 15.13%4.66B |
-General and administrative expense | 17.59%6.2B | 36.74%1.89B | 20.28%1.53B | 10.29%1.45B | 2.05%1.33B | 0.70%5.27B | -5.07%1.38B | -3.22%1.27B | 1.61%1.32B | 11.26%1.31B |
Other taxes | 263.22%64.8M | 68.86%-58.89M | -47.08%22.81M | -29.85%45.58M | -5.33%55.29M | 94.11%-39.7M | -249.72%-189.14M | -34.97%43.11M | 107.77%64.98M | 289.82%58.4M |
Other operating expenses | -23.31%-2.13B | -51.98%-845.19M | -11.03%-471.43M | -12.47%-430.26M | -26.35%-572.35M | -22.20%-1.72B | 5.36%-556.13M | -51.17%-424.59M | -18.45%-382.55M | -73.00%-453M |
Operating profit | 14.56%21.51B | 35.52%7.73B | 7.61%5.19B | 13.28%3.96B | -0.10%4.83B | 7.87%18.77B | 5.33%5.7B | 22.23%4.82B | -12.43%3.49B | 17.89%4.83B |
Net non-operating interest income expense | 23.08%-598.8M | -128.63%-51.26M | 31.63%-204.49M | 38.09%-209.09M | 48.05%-162.25M | 10.82%-778.5M | 715.26%179.01M | 55.34%-299.11M | -2,188.26%-337.72M | -95.92%-312.3M |
Non-operating interest income | 44.81%1.62B | 112.38%20.48M | 19.34%502.46M | 69.59%345.35M | 62.20%585.9M | 16.29%1.12B | 76.29%-165.46M | -14.61%421.04M | -73.50%203.63M | -9.83%361.22M |
Non-operating interest expense | -14.83%2.4B | -12.42%626.27M | -14.70%575.4M | -24.38%576.11M | -6.59%620.43M | -2.67%2.82B | -19.99%715.1M | -24.29%674.58M | 18.44%761.84M | 42.92%664.18M |
Total other finance cost | 80.84%-175.5M | 47.66%-554.53M | 188.76%131.56M | 90.17%-21.67M | 1,267.96%127.71M | 13.24%-915.8M | 32.19%-1.06B | -83.23%45.56M | -257.48%-220.48M | -90.20%9.34M |
Other net income (expense) | 51.98%-1.42B | 33.56%-768.61M | 32.20%-312.37M | 59.71%-315.4M | 70.54%-188.86M | -28.95%-2.96B | -9.22%-1.16B | 1.84%-460.74M | -80.02%-782.73M | -71.97%-641.14M |
Gain on sale of security | 64.89%-993.4M | 53.40%-227.5M | 48.27%-331.86M | 77.17%-176.63M | 75.02%-229.12M | 25.82%-2.83B | 58.87%-488.18M | 40.23%-641.56M | 8.56%-773.6M | -29.58%-917.07M |
Earnings from equity interest | 102.10%3.9M | 101.22%2.08M | 2,458.61%36.84M | -1,193.79%-31.45M | 74.81%-3.57M | -536.77%-185.3M | -704.96%-170.14M | 161.17%1.44M | 24.17%-2.43M | -489.52%-14.17M |
Special income (charges) | -868.63%-431.2M | 41.95%-214.26M | -160.43%-85.33M | -2,779.88%-175.44M | -84.89%43.83M | -96.38%56.1M | -266.91%-369.12M | -74.69%141.21M | -101.41%-6.09M | -14.00%290.1M |
-Less:Restructuring and merger&acquisition | -9.23%99.3M | 40.36%51.93M | 14.24%18.4M | -59.86%11.4M | -37.00%17.57M | 7.47%109.4M | -22.29%37M | 31.84%16.11M | 11.77%28.41M | 68.43%27.89M |
-Less:Other special charges | 672.95%453.2M | -42.65%208.74M | 168.75%99.93M | 2,469.49%185.25M | 85.96%-40.72M | 94.99%-79.1M | 239.18%363.98M | 73.63%-145.34M | 98.24%-7.82M | 9.53%-289.92M |
-Write off | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | 40.39%121.3M | 45.73%46.41M | 175.49%33M | 46.29%21.21M | -26.33%20.68M | -2.70%86.4M | 33.55%31.85M | -37.09%11.98M | 16.06%14.5M | -15.99%28.08M |
Other non- operating income (expenses) | ---- | ---- | 78.10%67.98M | 11,359.83%68.12M | ---- | ---- | ---- | -21.03%38.17M | 96.65%-605K | ---- |
Income before tax | 29.61%19.49B | 46.21%6.91B | 15.02%4.67B | 44.68%3.43B | 15.41%4.48B | 5.62%15.04B | 9.22%4.73B | 44.79%4.06B | -32.97%2.37B | 8.75%3.88B |
Income tax | 6,046.23%4.64B | 851.42%1.89B | 2,369.49%1.1B | 533.90%979.87M | 1,048.96%671.17M | 111.52%75.5M | 126.23%198.23M | 110.87%44.68M | -147.59%-225.83M | 58.84%58.42M |
Net income | -0.76%14.85B | 10.96%5.02B | -11.18%3.57B | -5.62%2.45B | -0.39%3.8B | 0.46%14.96B | -10.92%4.53B | 24.88%4.02B | -15.22%2.6B | 8.23%3.82B |
Net income continuous Operations | -0.76%14.85B | 10.96%5.02B | -11.18%3.57B | -5.62%2.45B | -0.39%3.8B | 0.46%14.96B | -10.92%4.53B | 24.88%4.02B | -15.22%2.6B | 8.23%3.82B |
Minority interest income | -10.64%409.7M | 2.42%144.19M | 2.68%106.03M | -41.36%55.58M | -13.18%103.91M | 5.82%458.5M | 20.86%140.78M | -2.99%103.26M | 0.51%94.79M | 3.11%119.67M |
Net income attributable to the parent company | -0.45%14.44B | 11.23%4.88B | -11.54%3.46B | -4.26%2.4B | 0.02%3.7B | 0.30%14.5B | -11.66%4.39B | 25.84%3.91B | -15.72%2.5B | 8.40%3.7B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -0.45%14.44B | 11.23%4.88B | -11.54%3.46B | -4.26%2.4B | 0.02%3.7B | 0.30%14.5B | -11.66%4.39B | 25.84%3.91B | -15.72%2.5B | 8.40%3.7B |
Basic earnings per share | -0.38%0.9176 | 10.71%0.31 | -11.43%0.22 | -4.15%0.1523 | 0.00%0.235 | 0.29%0.9211 | -15.15%0.28 | 25.77%0.2484 | -15.75%0.1589 | 8.39%0.235 |
Diluted earnings per share | -0.29%0.9129 | 10.71%0.31 | -11.38%0.2188 | -3.99%0.1516 | 0.04%0.2336 | 0.36%0.9156 | -15.15%0.28 | 25.91%0.2469 | -15.70%0.1579 | 8.45%0.2335 |
Dividend per share | -8.54%0.6701 | -8.54%0.6701 | 0 | 0 | 0 | -3.97%0.7327 | -3.97%0.7327 | 0 | 0 | 0 |
Currency Unit | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |